ID: ALA1224184

Max Phase: Preclinical

Molecular Formula: C31H29Cl2N3O7

Molecular Weight: 626.49

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)[C@H](Cc1ccc(OCc2c(Cl)cccc2Cl)cc1)NC(=O)[C@@H]1OCO[C@H]1C(=O)NCCc1c[nH]c2ccccc12

Standard InChI:  InChI=1S/C31H29Cl2N3O7/c32-23-5-3-6-24(33)22(23)16-41-20-10-8-18(9-11-20)14-26(31(39)40)36-30(38)28-27(42-17-43-28)29(37)34-13-12-19-15-35-25-7-2-1-4-21(19)25/h1-11,15,26-28,35H,12-14,16-17H2,(H,34,37)(H,36,38)(H,39,40)/t26-,27+,28+/m0/s1

Standard InChI Key:  WSLYGTJBLAWGMH-UPRLRBBYSA-N

Associated Targets(Human)

Integrin alpha-4 295 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 626.49Molecular Weight (Monoisotopic): 625.1383AlogP: 4.27#Rotatable Bonds: 12
Polar Surface Area: 138.98Molecular Species: ACIDHBA: 6HBD: 4
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 3.36CX Basic pKa: CX LogP: 4.82CX LogD: 1.41
Aromatic Rings: 4Heavy Atoms: 43QED Weighted: 0.18Np Likeness Score: -0.42

References

1. Rehman A, Soni A, Naik K, Nair S, Palle VP, Dastidar S, Ray A, Alam MS, Salman M, Cliffe IA, Sattigeri V..  (2010)  Synthesis and biological activity of N-substituted aminocarbonyl-1,3-dioxolanes as VLA-4 antagonists.,  20  (18): [PMID:20705461] [10.1016/j.bmcl.2010.07.069]

Source